Apellis Pharmaceuticals' Series B Round

Apellis Pharmaceuticals raised a round of funding on December 02, 2014.

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company, focused on the development of a platform of novel therapeutic compounds for the treatment of a broad range of autoimmune diseases…

Articles about Apellis Pharmaceuticals' Series B Round: